Literature DB >> 22459450

MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.

Jian-Yong Sun1, Yi Huang, Ji-Peng Li, Xiang Zhang, Lei Wang, Yan-Ling Meng, Bo Yan, Yong-Qian Bian, Jing Zhao, Wei-Zhong Wang, An-Gang Yang, Rui Zhang.   

Abstract

Recent profile studies of microRNA (miRNA) expression have documented a deregulation of miRNA (miR-320a) in human colorectal carcinoma. However, its expression pattern and underlying mechanisms in the development and progression of colorectal carcinoma has not been elucidated clearly. Here, we performed real-time PCR to examine the expression levels of miR-320a in colon cancer cell lines and tumor tissues. And then, we investigated its biological functions in colon cancer cells by a gain of functional strategy. Further more, by the combinational approaches of bioinformatics and experimental validation, we confirmed target associations of miR-320a in colorectal carcinoma. Our results showed that miR-320a was frequently downregulated in cancer cell lines and colon cancer tissues. And we demonstrated that miR-320a restoration inhibited colon cancer cell proliferation and β-catenin, a functionally oncogenic molecule was a direct target gene of miR-320a. Finally, the data of real-time PCR showed the reciprocal relationship between miR-320a and β-catenin's downstream genes in colon cancer tissues. These findings indicate that miR-320a suppresses the growth of colon cancer cells by directly targeting β-catenin, suggesting its application in prognosis prediction and cancer treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22459450     DOI: 10.1016/j.bbrc.2012.03.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  73 in total

1.  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Aaron J Schetter; Yoshinaga Okugawa; Curtis C Harris; C Richard Boland; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

Review 3.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.

Authors:  Jiaojiao Zhou; Mengwen Zhang; Yanqing Huang; Lin Feng; Hailong Chen; Yiwang Hu; Huarong Chen; Kaitai Zhang; Lei Zheng; Shu Zheng
Journal:  Cancer Lett       Date:  2014-10-16       Impact factor: 8.679

5.  MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3.

Authors:  Chao Shang; Hui Zhang; Yan Guo; Yang Hong; Yunhui Liu; Yixue Xue
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

6.  MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.

Authors:  Tianzhu Guo; Ying Feng; Qingyang Liu; Xue Yang; Tao Jiang; Yan Chen; Quangeng Zhang
Journal:  Tumour Biol       Date:  2014-08-13

Review 7.  Epigenetic alterations involved in cancer stem cell reprogramming.

Authors:  Purificación Muñoz; Maria S Iliou; Manel Esteller
Journal:  Mol Oncol       Date:  2012-10-26       Impact factor: 6.603

8.  MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.

Authors:  Jianguo Wang; Chunyun Shi; Jianfei Wang; Li Cao; Li Zhong; Dongmei Wang
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

9.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

Review 10.  Transient receptor potential channel C5 in cancer chemoresistance.

Authors:  Dong-xu He; Xin Ma
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.